Levosol (Levodropropizine)

Levodropropizine is a peripheral antitussive that works on the cough reflex pathway by blocking the release of sensory neuropeptides from airway afferent nerves. This action reduces the heightened cough sensitivity that occurs in conditions such as dry, non‑productive cough caused by irritation of the respiratory mucosa, viral upper‑respiratory infections, or allergic inflammation.

• Dry cough: Reduces cough frequency and intensity in patients with non‑productive cough.

• Levodropropizine acts peripherally on sensory nerve endings in the respiratory tract, inhibiting the release of neuropeptides such as substance P and calcitonin‑gene‑related peptide. By dampening afferent signaling, it lowers the sensitivity of the cough reflex without penetrating the central nervous system, providing cough relief while minimizing central side effects.

Levodropropizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Nausea: Mild stomach upset reported in some patients.
• Dizziness: Transient light‑headedness, especially on initial dosing.
• Headache: Occasional mild headache.
• Dry mouth: Reduced salivation leading to a sensation of dryness.

Serious or Rare Side Effects

• Allergic reaction: Rash, itching, or swelling indicating hypersensitivity.
• Anaphylaxis: Rare, severe systemic allergic response requiring emergency care.
• Hepatic dysfunction: Uncommon elevation of liver enzymes.
• Stevens‑Johnson syndrome: Very rare severe skin reaction.
• Blood dyscrasia: Rare hematologic abnormalities.

Levosol should be used with attention to patient‑specific factors and proper handling.

• Assess renal function: Adjust use in patients with severe renal impairment.
• Avoid in known hypersensitivity: Discontinue if allergic signs appear.
• Use caution in children: Pediatric safety has not been fully established.
• Monitor for CNS depression: Be vigilant when combined with other sedatives.
• Store at room temperature: Keep in the original pack, protect from moisture and direct sunlight.

Levodropropizine may interact with other medications, requiring careful management.

Major Interactions (Avoid)

• Co‑administration with other peripheral antitussives: Risk of excessive cough suppression.
• Use with CNS depressants: May enhance drowsiness or sedation.
• Combination with QT‑prolonging drugs: Potential for cardiac rhythm disturbances.

Moderate Interactions (Monitor Closely)

• Concurrent anticholinergic agents: May increase dry‑mouth sensation.
• Antacids: May affect the absorption of levodropropizine.